Alderley Park, UK – 10th January 2018. SurgaColl, a regenerative medicine company focussed on tissue repair, today announced the completion of its Series A funding, led by the GM&C Life Sciences Fund, and including investment from Julz Co, a US-based healthcare fund. SurgaColl Technologies is a medical device company developing novel… Read More